Family Office Of America (FOFA) Income from Continuing Operations (2021 - 2026)
Family Office Of America (FOFA) posted Income from Continuing Operations of 209049.0 for Q1 2026, up 185.94% sequentially from 243255.0 in Q4 2025, and up 302.33% YoY from 51959.63 in Q1 2025.
Family Office Of America (FOFA) Income from Continuing Operations (2021 - 2026) Analysis & Trends
Family Office Of America has reported Income from Continuing Operations for 6 years, with the latest figure at 209049.0 in Q1 2026.
- Quarterly Income from Continuing Operations rose 302.33% year-over-year to 209049.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 180378.0 (up 3.87% YoY) and the FY2025 annual result came in at 492748.0, down 390.37% from the prior year.
- Income from Continuing Operations climbed to 209049.0 in Q1 2026 per FOFA's latest filing, from 243255.0 in the prior quarter.
- Over five years, Income from Continuing Operations peaked at 943223.0 in Q4 2023 and troughed at 1639861.0 in Q2 2023.
- A 5-year average of 124101.12 and a median of 79811.0 in 2023 frame the typical range for Income from Continuing Operations.
- The sharpest annual moves came in 2023 and 2025: Income from Continuing Operations jumped 601.04% in 2023, then plunged 699.65% in 2025.
- Over 5 years, Income from Continuing Operations stood at 188254.0 in 2022, then surged by 601.04% to 943223.0 in 2023, then tumbled by 103.23% to 30420.0 in 2024, then sank by 699.65% to 243255.0 in 2025, then jumped by 185.94% to 209049.0 in 2026.
- According to Business Quant data, Income from Continuing Operations over the past three periods registered 209049.0, 243255.0, and 50944.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.51 Bn | 194.91 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 129.96 Bn | 126.48 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 120.18 Bn | 110.96 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 74.28 Bn | 73.74 Bn | 3.85 Bn | 905.00 Mn |
| 5 | Edwards Lifesciences | 52.75 Bn | 48.50 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.67 Bn | 32.73 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 34.23 Bn | 32.12 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.46 Bn | 23.14 Bn | 4.55 Bn | 1.04 Bn |
| 9 | Steris | 23.30 Bn | 22.82 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Family Office Of America | 27.84 Mn | 27.20 Mn | 532,674.00 | -125,146.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 209,049.00 |
| Dec 31, 2025 | -243,255.00 |
| Sep 30, 2025 | -50,944.00 |
| Jun 30, 2025 | -95,228.00 |
| Mar 31, 2025 | -103,321.00 |
| Dec 31, 2024 | -30,420.00 |
| Sep 30, 2024 | -22,676.00 |
| Jun 30, 2024 | -31,228.00 |
| Mar 31, 2024 | -16,160.00 |
| Dec 31, 2023 | 943,223.00 |
| Sep 30, 2023 | -28,572.00 |
| Jun 30, 2023 | -1.64 Mn |
| Mar 31, 2023 | -79,811.00 |
| Dec 31, 2022 | -188,254.00 |
| Sep 30, 2022 | -126,659.00 |
| Jun 30, 2022 | -510,529.00 |
| Mar 31, 2022 | -95,073.00 |
| Dec 31, 2021 | -386,442.00 |
| Sep 30, 2021 | -518,866.00 |
| Jun 30, 2021 | -622,777.00 |